Apimeds Pharmaceuticals US APUS Revenue Breakdown

NYSE APUS
$5.00 +0.05 (+1.01%)
At close: Sep 30, 2026 · 4:00 PM EDT
No revenue breakdown for APUS Apimeds Pharmaceuticals US does not report revenue split by segment, product or geography.